Juan M. Pericàs

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy et al. · New England Journal of Medicine · 2024 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis

Vivian H. Chu, Lawrence P. Park, Eugene Athan et al. · Circulation · 2014 · 274 citations · Full text

Medicine, Internal Medicine, Surgery +13

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

Lawrence P. Park, Vivian H. Chu, Gail Peterson et al. · Journal of the American Heart Association · 2016 · 205 citations · Full text

Public Health, Biostatistics, Surgery +17

Inequalities in global health inequalities research: A 50-year bibliometric analysis (1966-2015)

Lucinda Cash‐Gibson, Diego Fernando Rojas‐Gualdrón, Juan M. Pericàs et al. · PLoS ONE · 2018 · 204 citations · Full text

Public Health, Health Sciences, Global Health +13

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe

Jeffrey V. Lazarus, Mattias Ekstedt, Giulio Marchesini et al. · Journal of Hepatology · 2019 · 166 citations · Full text

Medicine, Health Policy, Public Health Practice +17